Filter
643
Filtered Results: 643
Text search:
nucleic
Acid
Featured
Recommendations
111
New Publications
158
Language
Document type
No document type
320
Guidelines
159
Studies & Reports
83
Manuals
44
Fact sheets
18
Training Material
6
Strategic & Response Plan
6
Situation Updates
3
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
42
Western and Central Europe
19
Global
17
Tanzania
12
South Africa
11
Eastern Europe
11
Africa
10
Latin America and the Carribbean
9
Ethiopia
9
Brazil
8
Nigeria
7
Nepal
6
Kenya
6
Liberia
6
Rwanda
5
Peru
5
East and Southern Africa
5
Bangladesh
5
Zambia
5
Myanmar / Burma
5
Ukraine
4
Asia
4
Congo, Democratic Republic of
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Russia
4
Angola
4
Colombia
3
El Salvador
3
Sierra Leone
3
Senegal
3
Germany
3
Argentina
3
Uganda
3
Namibia
3
China
2
Cameroon
2
Syria
2
Philippines
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
South–East Asia Region
2
Portugal
2
Vietnam
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Burkina Faso
1
Afghanistan
1
Italy
1
USA
1
Haiti
1
Cambodia
1
Western Pacific Region
1
Uruguay
1
France
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Georgia
1
Chad
1
Bhutan
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
113
Pharmacy & Technologies
46
Public Health
19
Key Resources
18
Women & Child Health
14
Capacity Building
4
Toolboxes
TB
128
COVID-19
112
HIV
75
NTDs
49
Rapid Response
44
Ebola & Marburg
23
Zika
17
AMR
15
Refugee
13
Pharmacy
12
Polio
6
Mental Health
4
Specific Hazards
4
Caregiver
4
Planetary Health
4
Conflict
3
Natural Hazards
2
Health Financing Toolbox
2
NCDs
2
Global Health Education
1
Cochrane Database of Systematic Reviews 2021, Issue 2. Art. No.: CD009593. DOI: 10.1002/14651858.CD009593.pub5.
The purpose of this document is to provide relevant information and guidelines on
coronavirus outbreaks – and in particular the novel coronavirus SARS-CoV-2 and the
diseases it produces, COVID-19 – for pharmacists and the pharmacy workforce, both in a
primary care context (i.e. community phar...
Following the encouraging initial results of the pilot project, the Ministry of Health is committed to increasing access to MDR-TB diagnosis, treatment and care. An expansion plan for the programmatic management of drug-resistant TB has been developed and forms part of the Five Year National Strateg...
This updated glossary for malaria aims to improve communication and mutual understanding within the scientific community, as well as with funding agencies, public health officials responsible for malaria programmes, and policy-makers in malaria-endemic countries
The third edition, released in 2018, has grown to include a total of 18 chapters, contributed by 20 experts and authors from many countries. The goal remains the same: to educate primary care providers on the best practices in TB diagnosis, treatment and follow-up. All articles are richly illustrate...
Antimicrobial resistance (AMR) is a major public health challenge, which is recognized as high priority area by the Government of India. The increasing consumption of antibiotics is one of the key drivers of antimicrobial resistance seen in bugs of public health importance. Irrational prescription o...
2nd edition, June 2021
This global guidance provided the framework for over 100 countries to develop their NDVPs. This updated (second) version supersedes the previous version published in 16 November 2020. New information has been added on the following areas:
the COVID-19 Partners Platform;
the use of COVID...
Division of Global Migration and Quarantine
April 16, 2012
Technical and operational ‘how-to’: practical considerations
PLOS ONE | https://doi.org/10.1371/journal.pone.0196239 April 23, 2018
В борьбе с туберкулезом достигнуты значительные прорывы, среди которых ускоренные и более точные методы диагностики и первые новые лекарственные средства за 50 л...
The objectives of these WHO guidelines are to provide updated evidence- based recommendations for the treatment of persons with hepatitis C infection using, where possible, all DAA-only combinations. The guidelines also provide recommendations on the preferred regimens based on a patient’s HCV gen...
